These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9826349)
1. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Power CA; Wei G; Bretscher PA Infect Immun; 1998 Dec; 66(12):5743-50. PubMed ID: 9826349 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
3. Immunization of newborn and adult mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced protection upon BCG challenge. Kiros TG; Power CA; Wei G; Bretscher PA Immunotherapy; 2010 Jan; 2(1):25-35. PubMed ID: 20635889 [TBL] [Abstract][Full Text] [Related]
4. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis. Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217 [TBL] [Abstract][Full Text] [Related]
5. Development of mixed Th1/Th2 type immune response and protection against Mycobacterium tuberculosis after rectal or subcutaneous immunization of newborn and adult mice with Mycobacterium bovis BCG. Lagranderie M; Balazuc AM; Abolhassani M; Chavarot P; Nahori MA; Thouron F; Milon G; Marchal G Scand J Immunol; 2002 Mar; 55(3):293-303. PubMed ID: 11940236 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice. Bonanni D; Rindi L; Lari N; Garzelli C J Med Microbiol; 2005 May; 54(Pt 5):443-448. PubMed ID: 15824420 [TBL] [Abstract][Full Text] [Related]
8. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis. Deng YH; Sun Z; Yang XL; Bao L Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318 [TBL] [Abstract][Full Text] [Related]
10. Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model. Janssen R; Kruisselbrink A; Hoogteijling L; Lamb JR; Young DB; Thole JE Immunology; 2001 Apr; 102(4):441-9. PubMed ID: 11328378 [TBL] [Abstract][Full Text] [Related]
11. Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen. Bruffaerts N; Pedersen LE; Vandermeulen G; Préat V; Stockhofe-Zurwieden N; Huygen K; Romano M PLoS One; 2015; 10(7):e0132288. PubMed ID: 26172261 [TBL] [Abstract][Full Text] [Related]
12. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group. Lozes E; Denis O; Drowart A; Jurion F; Palfliet K; Vanonckelen A; De Bruyn J; De Cock M; Van Vooren JP; Huygen K Scand J Immunol; 1997 Jul; 46(1):16-26. PubMed ID: 9246204 [TBL] [Abstract][Full Text] [Related]
13. Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system. Dhar N; Rao V; Tyagi AK Immunol Lett; 2003 Sep; 88(3):175-84. PubMed ID: 12941476 [TBL] [Abstract][Full Text] [Related]
14. Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Shibata Y; Honda I; Justice JP; Van Scott MR; Nakamura RM; Myrvik QN Infect Immun; 2001 Oct; 69(10):6123-30. PubMed ID: 11553551 [TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091 [TBL] [Abstract][Full Text] [Related]
16. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin. Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102 [TBL] [Abstract][Full Text] [Related]
17. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis. Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213 [TBL] [Abstract][Full Text] [Related]